Source:http://linkedlifedata.com/resource/pubmed/id/10416406
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
364
|
| pubmed:dateCreated |
1999-8-5
|
| pubmed:abstractText |
Seventy-six hips in 67 patients were evaluated an average of 119 months (range, 61-150 months) after total hip arthroplasty with porous coated Omnifit femoral and acetabular components. The patients were young (average age, 45 years), and most were male (67%). Two stems and one cup were revised for aseptic loosening, for aseptic revision rates of 2.6% on the femoral side and 1.3% on the acetabular side. Thigh pain was present in three cases, one of which was activity limiting. Twenty-five (35.7%) hips had evidence of osteolysis confined to proximal Gruen Zone 1 or 7 or to the acetabulum (22 proximal femoral, three both). There were no cases of intramedullary osteolysis in surviving stems. Thirteen (17.1%) hips have undergone reoperation for bone grafting of progressive proximal osteolysis without component revision, at an average 93 months after the total hip arthroplasty. At an average 40 months after reoperation, all stems remain well fixed, and there has been no recurrence of osteolysis of grafted femoral lesions. These results suggest that a circumferentially proximally porous coated femoral component in cementless total hip arthroplasty can provide stable fixation for as long as 12 years after implantation and caseal the canal from distal osteolysis. Serious concerns remain about the incidence of proximal femoral osteolysis.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jul
|
| pubmed:issn |
0009-921X
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
164-74
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:10416406-Adult,
pubmed-meshheading:10416406-Aged,
pubmed-meshheading:10416406-Arthroplasty, Replacement, Hip,
pubmed-meshheading:10416406-Bone Cements,
pubmed-meshheading:10416406-Bone Transplantation,
pubmed-meshheading:10416406-Coated Materials, Biocompatible,
pubmed-meshheading:10416406-Female,
pubmed-meshheading:10416406-Femur Head Necrosis,
pubmed-meshheading:10416406-Follow-Up Studies,
pubmed-meshheading:10416406-Hip Prosthesis,
pubmed-meshheading:10416406-Humans,
pubmed-meshheading:10416406-Male,
pubmed-meshheading:10416406-Middle Aged,
pubmed-meshheading:10416406-Osteoarthritis, Hip,
pubmed-meshheading:10416406-Osteolysis,
pubmed-meshheading:10416406-Pain, Postoperative,
pubmed-meshheading:10416406-Prosthesis Failure,
pubmed-meshheading:10416406-Reoperation,
pubmed-meshheading:10416406-Time Factors,
pubmed-meshheading:10416406-Treatment Outcome
|
| pubmed:year |
1999
|
| pubmed:articleTitle |
Omnifit cementless total hip arthroplasty. A 10-year average followup.
|
| pubmed:affiliation |
Orthopaedics Indianapolis, IN 46278, USA.
|
| pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|